Healius Limited · ASX:HLS
Healius — Shareholder Meeting (October 2022)
16 slides from Healius's shareholder meeting presentation, Oct 20, 2022
Slide 1: 2022 Annual General Meeting
2022 Annual General Meeting 20 October 2022
Slide 2: Jenny Macdonald, Chair and Non-executive Director
Jenny Macdonald Chair and Non-executive Director 2 2022 Annual General Meeting
Slide 3: Board of Directors
Board of Directors Jenny Macdonald Gordon Davis Sally Evans Dr Paul Jones Non-executive Chair Non-executive Director Non-executive Director Non-executive Director Dr Malcolm Parmenter Prof John Mattick Kate McKenzie Charles Tilley MD & CEO Non-executive Director Non-executive Director Company Secret
Slide 4: AGM Assistance
AGM Assistance If you require assistance during the meeting, call: + 61 3 9415 4024 For those in attendance please raise your hand and one of the Computershare team will assist you. 4 2022 Annual General Meeting
Slide 5: Board refresh and succession planning
Board refresh and succession planning • Thank you to Rob Hubbard and Paul Jones for their guidance and insights • Legacy of: • A good balance sheet • A streamlined portfolio • Multiple growth pathways • Look to: • Fill two Non-executive Director vacancies • Executive succession planning 5 2022 Annua
Slide 6: Healius' vision and strategy
Healius’ vision and strategy We aim to create sustainable value through personalised diagnoses in support of clinical decision-making across our national healthcare system Three pillars: • Insights for diagnosis • Service to referrers and patients • Investment in clinical domains Three drivers: • Re
Slide 7: Capital management and shareholder returns
Capital management and shareholder returns Balancing: • Strong balance sheet / target gearing ratio of 1.7-2.2x • Selective investment in organic initiatives and bolt-on M&As • Dividends to shareholders 7 2022 Annual General Meeting
Slide 8: Sustainability
Sustainability Healius aspires to be a socially responsible company that creates value for all stakeholders through its core values of care, compassion and quality 8 2022 Annual General Meeting
Slide 9: Dr Malcolm Parmenter, CEO and Managing Director
Dr Malcolm Parmenter CEO and Managing Director 9 2022 Annual General Meeting
Slide 10: Executive Leadership Team
Executive Leadership Team Dr Malcolm Parmenter Maxine Jaquet Janet Payne John McKechnie CEO and Managing Director CFO and COO Group Executive Corporate Affairs CEO Pathology Henry Barclay Prasad Arav Mark Neeham Peter Wilson CEO Day Hospitals Group Executive Group Executive Group Executive Digital a
Slide 11: FY 2022 year in review
FY 2022 year in review Group Underlying Reported $m FY 2022 FY 2021 FY 2022 FY 2021 Revenue 2,337.7 1,913.1 2,336.2 1,900.7 EBIT 492.3 266.5 467.4 255.4 NPAT 1 309.3 148.4 307.9 43.7 Dividend2 16.00 13.25 • Underlying NPAT doubled • Strong financial performance underpinned by: • Ability to scale up
Slide 12: Sustainable Improvement Program and Digital Agenda
Sustainable Improvement Program and Digital Agenda SIP • Substantial progress in FY22 including: • Collection centre optimisation • Procurement • On track to exit FY23 at target margins, assuming BAU recovery Digital Agenda • Rapidly introducing key customer innovations including: • E-referrals • Co
Slide 13: Streamlined portfolio
Streamlined portfolio • Streamlined portfolio of diagnostic businesses • Day Hospitals sales process underway to realise investment • We continue to grow: • Integration of Axis Diagnostics • Development of two NSW Imaging facilities • Roll-out of Lumus Imaging brand • Award of Hunter New England con
Slide 14: Trading update
Trading update Current trading • Non-COVID revenues up 5.5% on pcp: • Imaging progressive and strong above-market growth • Pathology growing more steadily but progressively • COVID testing now below 4,000 tests per working day • Reset cost base for 2H23 with closure of COVID infrastructure / alignme
Slide 15: Compelling competitive position
Compelling competitive position Scalable portfolio in attractive diagnostic markets Competitive networks and more profitable footprint Growing margins through SIP Compelling digital proposition and customer-centric re-orientation Broader growth options Reduced capital intensity and great
Slide 16: tthealius
tthealius